BetterInvesting Magazine's committee named Amazon.com (NASDAQ: AMZN) its “Stock to Study” and UnitedHealth Group (NYSE: UNH) its “Undervalued Stock” in the January–February 2027 issue, for informational and educational use. The organization says these picks are not endorsed or recommended for purchase by NAIC/BetterInvesting. It urges investors to conduct their own review using the Stock Selection Guide before making any investment decision. Non-members can access a limited trial version of the online analysis tools to view fundamental data for both companies.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related tickers and likely impact
AMZN
• NeutralAmazon
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Consumer Discretionary |
| Industry | Broadline Retail |
| Market cap | $2.6T |
| Close on 10/30/2026 | 240.47 |
| Change that session | -1.36% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Abbott Laboratories vs . UnitedHealth : Does Health Innovation or Health Insurance Make for a Better Stock to Buy ?
The article compares Abbott Laboratories (ABT), a maker of medical devices, diagnostics and nutrition products, with UnitedHealth Group (UNH), which runs the UnitedHealthcare insurance arm and Optum health services. In FY 2025 Abbott's revenue rose about 6% to $44.3 billion, but net income fell to about $6.5 billion from $13.4 billion, largely due to a $385 million settlement. UnitedHealth's revenue grew nearly 12% to about $447.6 billion, while net income dropped to about $12.1 billion from $14.4 billion, a net margin of about 2.7%. Medicaid and Medicare premiums made up 44% of UnitedHealth's 2025 revenue, exposing it to government policy, while Abbott faces FDA oversight and debt from its $20 billion acquisition of Exact Sciences. Free cash flow was about $7.4 billion for Abbott and about $16.1 billion for UnitedHealth in FY 2025.
- SteelPeak Wealth LLC Acquires 13 , 533 Shares of UnitedHealth Group Incorporated $UNH
SteelPeak Wealth LLC raised its UnitedHealth Group stake by 41.9% in the third quarter, buying 13,533 shares to reach 45,834 shares worth $16,825,000, according to a 13F filing with the SEC. Institutional investors and hedge funds hold 87.86% of the stock. UnitedHealth reported third-quarter adjusted EPS of $4.69 versus a $4.14 consensus and raised its 2026 adjusted EPS outlook to at least $20.50. Analysts are divided: JPMorgan raised its target to $524 and Goldman Sachs reportedly raised its target to $506, while TD Cowen kept a “hold” rating with a $402 target. The article also flags falling membership and high medical costs as concerns, and notes that CEO Patrick Conway sold 1,169 shares at $390.00 on August 21.
- Amazon's $2 Billion Data Center Faces Election Day Threat as Voters Weigh 41 AI Infrastructure Measures
Amazon could face a setback on Tuesday over its planned $2 billion data center in Ohio, as local residents vote on a measure that could block the project. The vote in Sunbury is one of 41 data-center ballot measures.
- Anthropic Reports Revenue Surge in First Nine Months, Net Loss Widens
- AWS Growth Wins Amazon Stock a $330 Upgrade
Phillip Securities upgraded Amazon to Buy from Accumulate on Monday and raised its price target from $320 to $330, arguing that AWS demand justifies the company's heavier spending. Amazon shares were up 5.22% as of 10:30 a.m. ET. Analyst Helena Wang raised her fiscal 2027 revenue estimate by 2%, net income forecast by 3% and capex estimate by 3%, while acknowledging that aggressive spending pressures free cash flow. In the third quarter, net sales rose 12% to $201.9 billion and AWS sales grew 39.3% to $46.0 billion, its fastest pace in nearly five years. Net income fell to $20.7 billion, or $1.89 per diluted share, because the year-ago quarter included $9.5 billion in pre-tax gains from the Anthropic investment.
- Why Amazon Stock Rallied Monday Morning
Amazon shares rose as much as 5.6% on Monday and were still up 4.6% at 11:52 a.m. ET, recovering from last week's slump. Phillip Securities analyst Helena Wang upgraded the stock to buy from accumulate and raised her price target to $330 from $320, citing strong demand visibility for cloud services and a growing suite of AI offerings. The stock had fallen after Q3 results, when Amazon reiterated capex plans of $220 billion for 2026, CEO Andy Jassy said spending would be meaningfully higher in 2027, and free cash flow was negative $42 billion. Jassy said the company has 'even more conviction' that these investments will yield a much larger revenue and free cash flow business. The author argues the valuation at 20 times earnings is near an all-time low and rates the stock a buy.
Related markets
Latest news
- AMD to report Q3 results following disappointing showing from Intel
AMD will report third-quarter results after the bell on Tuesday, as Wall Street looks for signs of AI chip demand after a sharp AI-trade sell-off and a disappointing Q4 outlook from Intel (INTC) last week. Intel guided Q4 revenue to $15 billion to $16 billion, well below the $17 billion analysts expected, sending its stock down nearly 29%; the company blamed a steeper-than-expected decline in the PC market. Analysts expect AMD to earn $1.97 per share on $13 billion in revenue, versus $1.20 and $9.2 billion a year earlier. Data Center sales are forecast at $8.19 billion, up 88% from $4.34 billion, while the gaming business could fall 49% to $655 million as higher memory and storage prices weigh on demand. Client revenue, which includes PC sales, is projected at more than $3.06 billion, up 11% year over year but flat sequentially.
- Why Musk's telecom play is no 'Hail Mary' fix
Two speakers discuss Elon Musk's push into telecoms over the past few months. One says the move may lift the stock briefly but is not a Hail Mary that will turn the business around, since telecom is heavily scrutinized for antitrust and not very lucrative; this speaker also doubts Musk's statements that funding is secured and wants to know what he is worried about in ongoing investigations. The other speaker views SpaceX's entry into telecoms positively, as a sign of diversification beyond AI and space, while the first asks when that could become an issue.
- Eli Lilly Just Delivered Another Blowout Quarter. Is This Unstoppable Growth Stock Still a Buy?
Eli Lilly reported third-quarter revenue up 39% year over year to $24.4 billion, driven mainly by GLP-1 drugs: Mounjaro rose 65% to $10.7 billion and Zepbound rose 49% to $5.4 billion. Non-GAAP earnings per share were $7.48, up 7%, held back by acquisition-related expenses, but both revenue and earnings beat analyst estimates. The company raised its full-year 2026 revenue guidance to $91 billion to $92 billion from $85 billion to $87 billion, and its shares jumped after the report. The article argues the GLP-1 market still has room to expand given low penetration, and views Lilly's pipeline, including retatrutide, as among the strongest in the field, while noting pricing pressure and competition from new medicines over the medium term.
- Why Lumentum Stock Fell 14.9% Today
Lumentum shares fell 14.9% intraday despite a strong first-quarter report, with revenue more than doubling 136.5% to $1.26 billion and adjusted EPS of $4.57. The company agreed to be acquired by Marvell Technology in an all-stock deal of 4.5 Marvell shares for each Lumentum share, with closing expected in the first half of calendar 2028. The deal was valued at $115 billion, or about $1,132 per Lumentum share, based on October 28 prices; at Monday's midday prices the offer was worth about $800 per share after Marvell fell 9.5%. Lumentum traded 10.6% below that implied value, and the two stocks together erased nearly $28 billion in market value on Monday. The companies expect more than $1 billion in annual cost savings.
- North Korea Is Laundering Binance Hack Loot at One New Wallet Every 25 Seconds
According to Elliptic, North Korean hackers spread the $6.43 billion stolen from Binance across about 12,000 wallets on 11 blockchains in under four days, with more than 40,000 transactions. Thanks to fast freezes by Tether and Circle, about 44% of the funds, or $2.85 billion, has been frozen or seized, compared with roughly 3% after the $1.5 billion Bybit hack in February 2025, though about $786 million in stablecoins still got away. About $3.24 billion remains in linked addresses, and Elliptic expects the funds to be cashed out over months through over-the-counter brokers. The FBI has attributed the attack to TraderTraitor, a North Korean state-linked hacking group.
- Is Apple the right anti-AI stock for investors to 'hide' in?
Commentators say Apple is priced near perfection, so even strong results may not meet expectations. Investors are said to be hiding in Apple as an 'anti-AI' stock because it has not spent heavily on AI buildout, while stocks that have spent heavily have been flat this year. One speaker calls Apple expensive but says its stability earns a premium, likening its ecosystem to a utility, and notes early reviews or figures on the foldable phone are mixed. Another says he would not sell even if the stock falls, but adds that if Apple disappoints, it is unclear where investors would go.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.